4KUY
Crystal structure of human carbonic anhydrase II in complex with the 5-(3-(o-tolylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | OXFORD DIFFRACTION ENHANCE ULTRA |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-05-06 |
Detector | OXFORD ONYX CCD |
Wavelength(s) | 1.542 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 42.210, 41.186, 71.956 |
Unit cell angles | 90.00, 104.19, 90.00 |
Refinement procedure
Resolution | 29.050 - 1.650 |
R-factor | 0.1589 |
Rwork | 0.157 |
R-free | 0.18870 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 3p58 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.200 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Refinement software | REFMAC |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 29.029 | 1.750 | |
High resolution limit [Å] | 1.650 | 4.890 | 1.650 |
Rmerge | 0.048 | 0.022 | 0.362 |
Number of reflections | 28318 | 1177 | 4039 |
<I/σ(I)> | 18.97 | 54.61 | 2.22 |
Completeness [%] | 97.5 | 99.2 | 87.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 8 | 296 | 1.5 M sodium citrate, Tris 50 mM, pH 8.0, vapor diffusion, temperature 296K |